Longeveron

Miami, United States

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

$30.0M raised

Mar 2026

Post Ipo Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Longeveron raised?

Longeveron has raised $30.0M in total funding. The most recent round was Post Ipo Equity. The last funding was announced in March 2026.

Who are Longeveron's investors?

Longeveron's investors include Janus Henderson Investors, TEDCO, Alzheimer's Association, Coastlands Capital, Logos Capital.

Where is Longeveron headquartered?

Longeveron is headquartered in Miami, United States.

What does Longeveron do?

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

What stage is Longeveron at?

Longeveron is at the Post Ipo Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 10, 2026.

MLA

"Longeveron — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/longeveron. Accessed July 2, 2026.

APA

VCBacked. (2026). Longeveron — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/longeveron

Wikipedia (cite web)

{{cite web |title=Longeveron — Funding & Investors |url=https://www.vcbacked.co/company/longeveron |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 10, 2026.